Z1031: Extended Follow-up Form Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer Source Form: NCI FormBuilder:

  1. 8/27/12 8/27/12 -
  2. 1/9/15 1/9/15 - Martin Dugas
Uploaded on:

January 9, 2015

To request one please log in.
License :
Creative Commons BY-NC 3.0 Legacy
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Endometrial Cancer NCT00265759 Follow-Up - Z1031: Extended Follow-up Form - 2316464v3.0

No Instruction available.

  1. StudyEvent: Z1031: Extended Follow-up Form
    1. No Instruction available.
Header Module
Vital status
Primary cause of death (If deceased,)
Was imaging done to assess for recurrence (Mam, U/S, MRI, etc.)
Notice Of First Recurrence/progression
Has the patient developed a first progression (or relapse) that has not been previously reported?
First recurrence/progression
Site of first recurrence/progression
Notice Of New Primary
Has a new primary cancer or MDS been diagnosed that has not been previously reported?
Footer Module

Similar models

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial